Drug, Healthcare and Patient Safety
Volume 16, 2024 - Issue
Open access
57
Views
0
CrossRef citations to date
0
Altmetric
CASE SERIES
Response to Osilodrostat Therapy in Adrenal Cushing’s Syndrome
Magdalena Stasiak1 Department of Endocrinology and Metabolic Diseases, Polish Mother’s Memorial Hospital—Research Institute, Lodz, PolandCorrespondence[email protected]
https://orcid.org/0000-0002-2910-7691View further author information
, https://orcid.org/0000-0002-2910-7691View further author information
Przemysław Witek2 Department of Internal Medicine, Endocrinology and Diabetes, Medical University of Warsaw; Mazovian Brodnowski Hospital, Warszawa, PolandView further author information
, Emilia Adamska-Fita1 Department of Endocrinology and Metabolic Diseases, Polish Mother’s Memorial Hospital—Research Institute, Lodz, PolandView further author information
& Andrzej Lewiński1 Department of Endocrinology and Metabolic Diseases, Polish Mother’s Memorial Hospital—Research Institute, Lodz, Poland;3 Department of Endocrinology and Metabolic Diseases, Medical University of Lodz, Lodz, Polandhttps://orcid.org/0000-0002-8748-3337View further author information
Pages 35-42
|
Received 27 Dec 2023, Accepted 20 Mar 2024, Published online: 08 Apr 2024
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.